Literature DB >> 29724725

Checkpoint inhibitor-associated immune arthritis.

Laurent Arnaud1, Bénédicte Lebrun-Vignes2, Joe-Elie Salem2.   

Abstract

Entities:  

Keywords:  autoimmune diseases; rheumatoid arthritis; systemic lupus erythematosus; treatment

Mesh：

Substances：

Year:  2018        PMID： 29724725     DOI： 10.1136/annrheumdis-2018-213470

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  8 in total

1.  Clinical Patterns and Follow-Up of Inflammatory Arthritis and Other Immune-Related Adverse Events Induced by Checkpoint Inhibitors. A Multicenter Study.

Authors:  José A Gómez-Puerta; David Lobo-Prat; Carolina Perez-García; Andrés Ponce; Beatriz Frade-Sosa; Ana Milena Millán Arciniegas; Fabiola Ojeda; Virginia Ruiz-Esquide; Hector Corominas
Journal:  Front Med (Lausanne)       Date:  2022-06-15

Review 2.  A Review of Cancer Immunotherapy Toxicity: Immune Checkpoint Inhibitors.

Authors:  Neeraj Chhabra; Joseph Kennedy
Journal:  J Med Toxicol       Date:  2021-04-07

Review 3.  Rheumatic Manifestations in Patients Treated with Immune Checkpoint Inhibitors.

Authors:  Konstantinos Melissaropoulos; Kalliopi Klavdianou; Alexandra Filippopoulou; Fotini Kalofonou; Haralabos Kalofonos; Dimitrios Daoussis
Journal:  Int J Mol Sci       Date:  2020-05-11       Impact factor: 5.923

4.  Neurologic toxicity associated with immune checkpoint inhibitors: a pharmacovigilance study.

Authors:  Douglas B Johnson; Ali Manouchehri; Alexandra M Haugh; Henry T Quach; Justin M Balko; Benedicte Lebrun-Vignes; Andrew Mammen; Javid J Moslehi; Joe-Elie Salem
Journal:  J Immunother Cancer       Date:  2019-05-22       Impact factor: 13.751

5.  Activated osteoarthritis following immune checkpoint inhibitor treatment: an observational study.

Authors:  Pankti Reid; David Fl Liew; Rajshi Akruwala; Anne R Bass; Karmela K Chan
Journal:  J Immunother Cancer       Date:  2021-09       Impact factor: 12.469

Review 6.  Gastrointestinal disorders as immune-related adverse events.

Authors:  Daniele Balducci; Claudia Quatraccioni; Antonio Benedetti; Marco Marzioni; Luca Maroni
Journal:  Explor Target Antitumor Ther       Date:  2021-04-30

7.  A case report of immune-mediated arthritis in a patient with cutaneous melanoma receiving checkpoint inhibition therapy.

Authors:  George Papaxoinis; Amalia Anastasopoulou; Katerina Laskari; Panagiotis Diamantopoulos; Olga Benopoulou; Helen Gogas
Journal:  Medicine (Baltimore)       Date:  2020-03       Impact factor: 1.817

8.  Higher Checkpoint Inhibitor Arthritis Disease Activity may be Associated With Cancer Progression: Results From an Observational Registry.

Authors:  Karmela Kim Chan; Aidan Tirpack; Gregory Vitone; Caroline Benson; Joseph Nguyen; Nilasha Ghosh; Deanna Jannat-Khah; Vivian Bykerk; Anne R Bass
Journal:  ACR Open Rheumatol       Date:  2020-10-03
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.